Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Skoop
AddedFeb 16, 2024
UpdatedJun 18, 2026
Skoop

Skoop

Angel

Skoop: Organic superfood supplements for health, fighting disease and inflammation.

HQ
Boulder, CO, US
Founded
2013
Overview
Compare
Fundraising
Employees

Skoop is a company dedicated to fighting disease, inflammation and general un-awesomeness with pure, clean and organic superfoods. Skoop A-Game is a synergistic blend of science, nature-functional food and your body's natural chemistry.

I have lived the last 30 years as a student and teacher of lifestyle medicine. Creating functional superfood blends and feeding their power to my friends and patients is my life's passion.

Skoop - Similar Companies

Your Super logo

Your Super

yoursuper.com

Smpl logo

Smpl

Balance the Superfood Shot logo

Balance the Superfood Shot

superfoodshot.com

Rdcl Superfoods logo

Rdcl Superfoods

rdclsuperfoods.com

Organic Avenue logo

Organic Avenue

organicavenue.com

Spoonfuls logo

Spoonfuls

getspoonfuls.com

MegaPlants logo

MegaPlants

megaplants.com

Orgain logo

Orgain

drinkorgain.com

Stamba logo

Stamba

Retreat Foods logo

Retreat Foods

retreatfoods.com

KOS logo

KOS

kos.com

aila logo

aila

meetaila.com

Plantnrgy logo

Plantnrgy

Four Sigmatic logo

Four Sigmatic

foursigmatic.com

Spicy Organic logo

Spicy Organic

spicyorganic.com

Skoop - Quick Facts

Who are Skoop's competitors?

Companies similar to Skoop include Your Super, Smpl, Balance the Superfood Shot and Rdcl Superfoods.

When was Skoop founded?

Skoop was founded in 2013.

Where is Skoop's headquarters located?

Skoop's headquarters is located in Boulder, CO, US.

When was Skoop's last funding round?

Skoop's most recent funding round was for $260k (USD) in September 2017.

How much has Skoop raised to-date?

As of Sep 1, 2017, Skoop has raised a total of $2.1M (USD).

How many employees does Skoop have?

Skoop has 8 employees as of Feb 4, 2024.

Skoop - Classification

Ownership
  • Private
Technology
  • Organic
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Superfoods
  • Supplements
Tags
  • eCommerce
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified